Fort Lauderdale

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Macular degeneration1 trial

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Intra-Cellular Therapies, Inc.2 trials
• Outlook Therapeutics, Inc.1 trial

Closed trials

• Completed

  A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT06190093· Phase 3· Outlook Therapeutics, Inc.· Source

• Completed

  An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061719· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT04985942· Phase 3· Intra-Cellular Therapies, Inc.· Source